← back to search

Coleman Rotstein

University Health Network · CA
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Neutropenia and Cancer Infections, and Transplantation: Methods and Outcomes.
h-index
43
citations
9,765
works
443
NIH funding
primary concept
Medicine
email

Recent publications

Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases 2025cited by 262position: middledoi
Clinical Practice Recommendations on the Effect of COVID-19 Vaccination Strategies on Outcomes in Solid Organ Transplant Recipients.
2025cited by 2position: contributordoi
Brief Report on Primary Cutaneous Invasive Aspergillosis in a Patient With Prolonged Neutropenia Following a Traumatic Injury.
2025cited by 0position: contributordoi
Measles Outbreaks and Implications for Patients Receiving Stem Cell or Cellular Therapies in Canada: Cell Therapy Transplant Canada (CTTC) Infectious Diseases Working Committee.
2025cited by 0position: contributordoi
Chronic Antibiotic Prophylaxis to Prevent Recurrent Cholangitis in Liver Transplant Recipients
Clinical Transplantation 2025cited by 0position: contributordoi
Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: A systematic review and network meta-analysis.
2024cited by 4position: contributordoi
Microbiological and Clinical Outcomes of Methicillin-Susceptible <i>Staphylococcus aureus</i> Isolated in Lung Transplant Perioperative Donor and Recipient Respiratory Cultures.
2023cited by 0position: contributordoi
Epidemiology of candidemia in lung transplant recipients and risk factors for candidemia in the early posttransplant period in the absence of universal antifungal prophylaxis.
2022cited by 10position: contributordoi
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada.
2022cited by 6position: contributordoi
<i>Strongyloides</i> hyper-infection in a lung transplant recipient: Case report and review of the literature.
2022cited by 6position: contributordoi
Implementation of a Routine Screening Program for Latent Tuberculosis Infection among Patients with Acute Leukemia at a Canadian Cancer Center.
2022cited by 5position: contributordoi
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
The Lancet Infectious Diseases 2021cited by 426position: middledoi
The economic impact of increased length of stay associated with surgical site infections in liver transplantation on Canadian healthcare costs.
2021cited by 7position: contributordoi
Clinical predictors of progression and clearance of low-level CMV DNAemia in solid organ transplant recipients.
2020cited by 12position: contributordoi
Granuloma in the explanted lungs: Infectious causes and impact on post-lung transplant mycobacterial infection.
2020cited by 6position: contributordoi
Correlation of intraoperative donor duodenal-segment swab cultures with the subsequent occurrence of surgical site infections in kidney and pancreas transplant recipients.
2020cited by 1position: contributordoi
Mycobacterium mucogenicum and Mycobacterium neoaurum Bloodstream Infection in Immunocompromised Hosts
2020cited by 0position: contributordoi
<i>Candida</i> infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Clinical Transplantation 2019cited by 156position: middledoi
Clinical predictors of progression and clearance of low‐level CMV DNAemia in solid organ transplant recipients
Transplant Infectious Disease 2019cited by 12position: middledoi
Symptomatic BK virus cystitis in non-renal transplant recipients.
2019cited by 3position: contributordoi
Cytokine profile in lung transplant recipients with Aspergillus spp colonization.
2019cited by 3position: contributordoi
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
Clinical Infectious Diseases 2018cited by 178position: middledoi
Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008
PLoS ONE 2014cited by 400position: middledoi
Efficacy of micafungin in invasive candidiasis caused by common <i>Candida</i> species with special emphasis on non‐<i>albicans Candida</i> species
Mycoses 2013cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 17 papers (2019–2025)Shahid Husain · University Health Network6 papers (2019–2022) · 4 papers (2020–2022)Deepali Kumar · University Health Network3 papers (2019–2021)Nazia Selzner · University Health Network2 papers (2019–2020)Farid Foroutan · University Health Network2 papers (2019–2025)José A. Vázquez · Augusta University2 papers (2013–2018)Peter G. Pappas · University of Alabama at Birmingham2 papers (2013–2018) · 2 papers (2019–2025)Sagar Kothari · Princess Margaret Cancer Centre2 papers (2022–2025)S. Frédéric Dufresne · Hôpital Maisonneuve-Rosemont2 papers (2022–2025)Lianne Singer · Clarivate PLC2 papers (2019–2022)Natasha Aleksova · Toronto Public Health2 papers (2024–2025) · 2 papers (2020–2021)Dima Kabbani · University of Alberta2 papers (2020–2025)Jan J. De Waele · Hôpital Saint Eloi2 papers (2013–2018)David R. Andes · University of Wisconsin–Madison1 papers (2014–2014) · 1 papers (2018–2018)Ploenchan Chetchotisakd · Indiana University – Purdue University Indianapolis1 papers (2018–2018)Raoul Herbrecht · Amgen (United States)1 papers (2018–2018)